Miriam Frech
Giessen, HE 35043, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells.
Journal: Nucleic acids research
Published: July 01, 2023
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP.
Journal: Cell communication and signaling : CCS
Published: January 15, 2023
A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis.
Journal: Bioengineering (Basel, Switzerland)
Published: September 26, 2022
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC.
Journal: Cancers
Published: September 03, 2020
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1.
Journal: Nucleic acids research
Published: November 27, 2017
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia.
Journal: Oncotarget
Published: July 26, 2017
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.
Journal: Haematologica
Published: January 07, 2017
Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.
Journal: Stem cell research & therapy
Published: December 14, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026